Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 3,889,000 | 3,811,000 | 4,441,000 | 4,065,000 | 4,048,000 |
| Cost of Goods | 991,000 | 968,000 | 1,273,000 | 1,175,000 | 1,108,000 |
| Gross Profit | 2,898,000 | 2,843,000 | 3,168,000 | 2,890,000 | 2,940,000 |
| Operating Expenses | 2,450,000 | 1,858,000 | 2,299,000 | 2,072,000 | 2,410,000 |
| Operating Income | 448,000 | 985,000 | 869,000 | 818,000 | 530,000 |
| Pre-tax Income | 448,000 | 985,000 | 869,000 | 818,000 | 530,000 |
| Income Tax | 114,000 | 49,000 | 134,000 | 126,000 | 0 |
| Net Income Continuous | 334,000 | 936,000 | 735,000 | 692,000 | 530,000 |
| Minority Interests | 1,000 | -1,000 | 9,000 | 0 | -6,000 |
| Net Income | $333,000 | $937,000 | $726,000 | $692,000 | $536,000 |
| EPS Basic Total Ops | 0.20 | 0.57 | 0.44 | 0.42 | 0.33 |
| EPS Basic Continuous Ops | 0.20 | 0.57 | 0.45 | 0.42 | 0.32 |
| EPS Diluted Total Ops | 0.20 | 0.56 | 0.43 | 0.42 | 0.32 |
| EPS Diluted Continuous Ops | 0.20 | 0.56 | 0.44 | 0.42 | 0.32 |
| EBITDA(a) | $483,000 | $1,202,000 | $1,050,000 | $998,000 | $719,000 |